Persistent benefit with RNAi targeting TTR in patients with ATTR cardiac amyloidosis

3' education - May 25, 2023 - Marianna Fontana, MD, PhD - London, UK

Educational information

This video was recorded during the ESC Heart Failure 2023 in Prague, Czech Republic.

Faculty

Marianna Fontana is the Director of the UCL CMR unit at the Royal Free Hospital. She is Professor of Cardiology and Honorary Consultant Cardiologist at the National Amyloidosis Centre, Division of Medicine, University College London, VK.

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

Read our summary of this interim analysis

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.